Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yemi Oluboyede

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Ophthalmology and Therapy|June 28, 2025
The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North AmericaDavid Tabano, Arjun Watane, Richard Gale, et al.
Health and Quality of Life Outcomes|September 20, 2024
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancerSiobhan Bourke, Bryan Bennett, Yemi Oluboyede, et al.
JHEP Reports : Innovation in Hepatology|May 22, 2020
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosisLorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, et al.
Health Technology Assessment (Winchester, England)|November 13, 2015
Effectiveness and acceptability of parental financial incentives and quasi-mandatory schemes for increasing uptake of vaccinations in preschool children: systematic review, qualitative study and discrete choice experimentJean Adams, Belinda Bateman, Frauke Becker, et al.
BMJ Open|September 19, 2022
Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm studySarah Dunn, Victoria Brocklebank, Andrew Bryant, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUSGiovany Orozco-Leal, Luke Vale, Yemi Oluboyede, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Trials|February 15, 2020
Nasal Airway Obstruction Study (NAIROS): a phase III, open-label, mixed-methods, multicentre randomised controlled trial of septoplasty versus medical management of a septal deviation with nasal obstructionKatherine J Rennie, James O'Hara, Nikki Rousseau, et al.
Health Technology Assessment (Winchester, England)|December 9, 2022
Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCTMichael Nugent, Valerie Bryant, Chrissie Butcher, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 26, 2026
A UK value set for the EQ-5D-5LDonna Rowen, Clara Mukuria, Nathan Bray, et al.
Ophthalmology and Therapy|June 28, 2025
The Economic Burden of Anti-Vascular Endothelial Growth Factor on Patients and Caregivers in the UK, Europe, and North AmericaDavid Tabano, Arjun Watane, Richard Gale, et al.
Health and Quality of Life Outcomes|September 20, 2024
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancerSiobhan Bourke, Bryan Bennett, Yemi Oluboyede, et al.
JHEP Reports : Innovation in Hepatology|May 22, 2020
Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosisLorraine McSweeney, Matthew Breckons, Gulnar Fattakhova, et al.
Health Technology Assessment (Winchester, England)|November 13, 2015
Effectiveness and acceptability of parental financial incentives and quasi-mandatory schemes for increasing uptake of vaccinations in preschool children: systematic review, qualitative study and discrete choice experimentJean Adams, Belinda Bateman, Frauke Becker, et al.
BMJ Open|September 19, 2022
Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm studySarah Dunn, Victoria Brocklebank, Andrew Bryant, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2025
Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUSGiovany Orozco-Leal, Luke Vale, Yemi Oluboyede, et al.
The Lancet Regional Health. Europe|January 19, 2026
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trialAndrew Bryant, Jan Lecouturier, Giovany Orozco-Leal, et al.
Trials|February 15, 2020
Nasal Airway Obstruction Study (NAIROS): a phase III, open-label, mixed-methods, multicentre randomised controlled trial of septoplasty versus medical management of a septal deviation with nasal obstructionKatherine J Rennie, James O'Hara, Nikki Rousseau, et al.
Health Technology Assessment (Winchester, England)|December 9, 2022
Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCTMichael Nugent, Valerie Bryant, Chrissie Butcher, et al.
Pageof 5